Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Our pharmacy network ensures safe and timely delivery
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 12 Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date Authors Pearson S , Kietsiriroje N , Ajjan RA Received 4 September 2019 Accepted for publication 8 November 2019 Published 2 December 2019 Volume 2019:12 Pages 25152529 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Ming-Hui Zou Sam Pearson, 1, * Noppadol Kietsiriroje, 1, 2, * Ramzi A Ajjan 1 1 Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK
Ecnoglutide A long-acting GLP-1 receptor agonist designed for twice-monthly or potentially monthly dosing
The Homekit arrived quickly and contained everything necessary for my injections
